Tarsus Pharmaceuticals
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company.
| Company Details | |
|---|---|
| Title | Tarsus Pharmaceuticals |
| Industries | Biopharma, Biotechnology, Life Science |
| Headquarters Regions | Greater Los Angeles Area, West Coast, Western US |
| Headquarters Location | Irvine, California, United States |
| No Of Employees | 1-10 |
| Operating Status | Active |
Description
Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.